Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma: are tumour neoantigens the answer? (#18)
James Lonie
1
2
,
Sandra Brosda
1
,
Venkat Addala
3
,
Nicola Waddell
3
,
Riccardo Dolcetti
1
4
5
,
Andrew Barbour
1
2
- Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane
- Upper Gastro-intestinal and Soft Tissue Unit, Princess Alexandra Hospital, Brisbane
- QIMR Berghoffer, Brisbane
- Clinical and Translational Immunotherapy , Peter MacCallum Cancer Centre, Melbourne
- University of Melbourne, Melbourne